Modulating osteoclasts with nanoparticles: A path for osteoporosis management?

Loading...
Thumbnail Image
Identifiers
ISSN: 1939-5116
E-ISSN: 1939-0041

Publication date

Advisors

Tutors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Wiley
Metrics
Google Scholar
lacobus
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Osteoclasts are the cells responsible for the bone resorption process during bone remodeling. In a healthy situation, this process results from an equilibrium between new matrix formation by osteoblast and matrix resorption by osteoclast. Osteoporosis (OP) is a systemic bone disease characterized by a decreased bone mass density and alterations in bone microarchitecture, increasing fracture pre disposition. Despite the variety of available therapies for OP management there is a growing gap in its treatment associated to the low patients´ adherence owing to concerns related with long-term efficacy or safety. This makes the development of new and safe treatments necessary. Among the newly developed strategies, the use of synthetic and natural nanoparticles to modulate osteoclasts differentiation, activity, apoptosis or crosstalk with osteoblasts have arisen. Synthetic nanoparticles exert their therapeutic effect either by loading antiresorptive drugs or including molecules for osteoclasts gene regulation. Moreover, this control over osteoclasts can be improved by their targeting to bone extracellular matrix or osteoclast membranes. Furthermore, natural nanoparticles, also known as extracellular vesicles, have been identified to play a key role in bone homeostasis. Consequently, these systems have been widely studied to control osteoblasts and osteoclasts under variable environments. Additionally, the ability to bioengineer extracellular vesicles has allowed to obtain biomimetic systems with desirable characteristics as drug carriers for osteoclasts. The analyzed information reveals the possibility of modulating osteoclasts by different mechanisms through nanoparticles decreasing bone resorption. These findings suggest that controlling osteoclast activity using nanoparticles has the potential to improve osteoporosis management. This article is categorized under: Implantable Materials and Surgical Technologies > Nanomaterials and Implants Implantable Materials and Surgical Technologies > Nanotechnology in Tissue Repair and Replacement Nanotechnology Approaches to Biology > Nanoscale Systems in Biology

Description

Bibliographic citation

Rouco, H., García-García, P., Briffault, E., & Diaz-Rodriguez, P. (2023). Modulating osteoclasts with nanoparticles: A path for osteoporosis management? WIREs Nanomedicine and Nanobiotechnology, e1885. https://doi.org/10.1002/wnan.1885

Relation

Has part

Has version

Is based on

Is part of

Is referenced by

Is version of

Requires

Sponsors

Patricia García-García acknowledges the University of La Laguna for the action “Recualificación de personal universitario: Margarita Salas para la formación de jóvenes doctores”. Helena Rouco acknowledges the University of Santiago de Compostela for the action “Recualificación de personal universitario: Margarita Salas para la formación de jóvenes doctores”. This work was funded by MCIN/AEI/10.13039/501100011033/FEDER, UE, (PID2021-127493OA-C22)

Rights

© 2023 The Authors. WIREs Nanomedicine and Nanobiotechnology published by Wiley Periodicals LLC. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited
Atribución 4.0 Internacional